Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: AstraZeneca, Boxing Day, Britain's economy

Sun, 27th Dec 2020 12:39

(Sharecast News) - The chief executive of AstraZeneca has raised hopes its vaccine with Oxford is more effective than first thought amid the rapid spread of the new UK virus strain across the globe. Pascal Soriot said he believed researchers had found the "winning formula" using two doses and promised to publish the results as reports suggested the UK regulator could approve the jab within days. - Sunday Telegraph

Footfall at the Boxing Day sales was down by more than half on last year as non-essential retail remained closed in much of the country under tightened coronavirus restrictions. While queues were seen outside shops in areas under tiers 2 and 3, high streets in the 43% of England that is under tier 4 were empty. The retail intelligence agency Springboard said Boxing Day footfall in the UK up to 10am was down 57% compared with last year. - Guardian

Britain's economy will outperform European rivals such as France over the next 15 years, according to morale-boosting forecasts published in the wake of the Government's Brexit trade deal with Brussels. A new ranking shows the UK remaining the world's 5th biggest economy next year. From 2025 it slips one place, but still performs better than many peer western economies. The UK's economy will be 23pc larger than that of France by 2035, the Centre for Economics and Business Research (CEBR) predicts. - Sunday Telegraph

The car industry is in a race against time to build giant battery gigafactories in the UK to ensure its survival and avoid damaging tariffs from the Brexit trade deal. Details of the EU deal revealed that Britain has a six-year window to build its supply of electric vehicle parts - either domestically or from the Continent - if it wants to continue selling them tariff-free to Europe. - Sunday Times

Bankers are gearing up for a surge of flotations on the London Stock Exchange next year as companies that delayed listing their shares due to the pandemic press ahead with plans to tap public markets. Dealmakers said they expect a boom in initial public offerings (IPOs) driven by pent up demand after pandemic disruption effectively halted new listings for much of 2020. Advisers predicted increased investor appetite for tech and healthcare firms that have done well in the crisis. - Sunday Telegraph

More than three-quarters of MPs are expected to dial in remotely to a debate that will consider the government's Brexit deal on Wednesday. The majority of MPs are preparing to participate online after the Commons speaker urged them to stay at home and made it clear those present in person will not be given priority to speak. Both the Commons and the Lords will sit for a single day on December 30 to pass the Future Relationship Bill implementing the government's free trade deal with the EU. - Sunday Times

Industry figures are calling on EU leaders to urgently agree a Brexit "adjustment period" after negotiators left them with just three working days to prepare for the end of the Brexit transition period. While big business including manufacturers and supermarkets have made Brexit preparations costing hundreds of millions of pounds, they say there is not enough time over Christmas to implement the newly agreed trading regime. - Guardian

The Bank of England could pull the trigger on negative interest rates if strict coronavirus restrictions are extended well into the new year, leading economists have warned. Interest rates are at record lows of 0.1%, leaving rate-setters with little room to move and raising the prospect of negative rates in the UK for the first time. - Sunday Times

City veteran Keith Skeoch has been appointed by the Treasury to lead a review of banking regulations in what could be the biggest overhaul of the sector since the fallout of the financial crisis a decade ago. The former chief executive of Standard Life Aberdeen will revisit the stringent rules put in place to rein in banks after several were bailed out by the Government in 2008, including Royal Bank of Scotland, Lloyds TSB and HBOS. - Financial Mail on Sunday
More News
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more
19 Feb 2024 08:36

TOP NEWS: AstraZeneca celebrates Tagrisso approval and new data

(Alliance News) - AstraZeneca PLC on Monday announced new study data and a new approval for its cancer medication Tagrisso.

Read more
19 Feb 2024 08:03

AstraZeneca's Tagrisso gains FDA approval

(Sharecast News) - Drugmaker AstraZeneca traded higher early on Monday after revealing that a combination of its cancer drug Tagrisso with chemotherapy had gained US approval to treat a particular type of lung cancer.

Read more
19 Feb 2024 07:49

LONDON BRIEFING: MoneySupermarket credits Insurance for growth in 2023

(Alliance News) - Stocks in London are set to fall at Monday's open, as concerns over US inflation trends curb risk appetite, and damp hopes of interest rate cuts from the Federal Reserve.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.